[Molecular aspects of connective tissue fibrillogenesis disorders caused by drug ligands].
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D003094:Collagen / Q000378:metabolism*; D003095:Collagen Diseases / Q000139:chemically induced*; D004549:Elastin / Q000378:metabolism*; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007538:Isoniazid / Q000009:adverse effects; D008024:Ligands; D010396:Penicillamine / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D008249:Protein-Lysine 6-Oxidase / Q000378:metabolism
D008024:Ligands; D006830:Hydralazine; D010672:Phenytoin; D003094:Collagen; D004549:Elastin; D008249:Protein-Lysine 6-Oxidase; D010396:Penicillamine; D011342:Procainamide; D007538:Isoniazid
Molekuliarnye aspekty narusheniia fibrillogeneza soedinitel'noĭ tkani lekarstvennymi ligandami.